Vaxxilon aims to simplify vaccine development by replacing biological components with well-defined synthetic molecules.

BASEL OFFICE

Vaxxilon AG
Christoph Merian-Ring 11
4153 Reinach Switzerland

BERLIN OFFICE

Vaxxilon Deutschland GmbH
Magnusstraße 11
12489 Berlin, Germany